Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 12, Issue 7, pp. 1171-1179
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 4, 2012
- Revision received April 17, 2013
- Accepted April 17, 2013
- Published first April 24, 2013.
Article Versions
- Previous version (April 24, 2013 - 14:18).
- Previous version (June 27, 2013 - 14:10).
- You are viewing the most recent version of this article.
Copyright & Usage
©2013 American Association for Cancer Research.
Author Information
- Roberto A. Salas Fragomeni1,2,
- Hye Won Chung1,2,
- Yosef Landesman5,
- William Senapedis5,
- Jean-Richard Saint-Martin5,
- Hensin Tsao1,3,
- Keith T. Flaherty1,4,
- Sharon Shacham5,
- Michael Kauffman5, and
- James C. Cusack1,2
- Authors' Affiliations: 1Harvard Medical School; 2Division of Surgical Oncology, Departments of 3Dermatology and 4Medicine, Hematology/Oncology, Massachusetts General Hospital, Boston; and 5Karyopharm Therapeutics, Natick, Massachusetts
- Corresponding Author:
James C. Cusack, Division of Surgical Oncology, Massachusetts General Hospital, Yawkey 7th Floor, 55 Fruit Street, Boston, MA 02114. Phone: 617-724-4093; Fax: 617-724-3895; E-mail: jcusack{at}partners.org
July 2013
Volume 12, Issue 7
Volume 12, Issue 7
CRM1 and BRAF Inhibition Synergize and Induce Tumor Regression in BRAF-Mutant Melanoma
Jump to section
Advertisement